vs
艾伯维（ABBV）与SYNTEC OPTICS HOLDINGS, INC.（OPTX）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是SYNTEC OPTICS HOLDINGS, INC.的2214.2倍（$16.6B vs $7.5M）。艾伯维净利率更高（10.9% vs -4.6%，领先15.5%）。艾伯维同比增速更快（10.0% vs 2.5%）。艾伯维自由现金流更多（$4.9B vs $-4.4K）。过去两年艾伯维的营收复合增速更高（16.2% vs 9.5%）
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业，专注于研发、生产覆盖多种疾病领域的治疗药物，致力于为全球各地患者提供安全有效的临床解决方案，在全球医药行业拥有较高的知名度与影响力。
ABBV vs OPTX — 直观对比
营收规模更大
ABBV
是对方的2214.2倍
$7.5M
营收增速更快
ABBV
高出7.5%
2.5%
净利率更高
ABBV
高出15.5%
-4.6%
自由现金流更多
ABBV
多$4.9B
$-4.4K
两年增速更快
ABBV
近两年复合增速
9.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $16.6B | $7.5M |
| 净利润 | $1.8B | $-343.8K |
| 毛利率 | 72.6% | 23.6% |
| 营业利润率 | 27.3% | 4.2% |
| 净利率 | 10.9% | -4.6% |
| 营收同比 | 10.0% | 2.5% |
| 净利润同比 | 8354.5% | 77.7% |
| 每股收益（稀释后） | $1.02 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABBVOPTX
| Q4 25 | $16.6B | $7.5M | ||
| Q3 25 | $15.8B | $7.0M | ||
| Q2 25 | $15.4B | $6.6M | ||
| Q1 25 | $13.3B | $7.1M | ||
| Q4 24 | $15.1B | $7.3M | ||
| Q3 24 | $14.5B | $7.9M | ||
| Q2 24 | $14.5B | $7.0M | ||
| Q1 24 | $12.3B | $6.3M |
净利润ABBVOPTX
| Q4 25 | $1.8B | $-343.8K | ||
| Q3 25 | $186.0M | $-1.4M | ||
| Q2 25 | $938.0M | $-343.9K | ||
| Q1 25 | $1.3B | $323.7K | ||
| Q4 24 | $-22.0M | $-1.5M | ||
| Q3 24 | $1.6B | $-13.3K | ||
| Q2 24 | $1.4B | $281.8K | ||
| Q1 24 | $1.4B | $-1.2M |
毛利率ABBVOPTX
| Q4 25 | 72.6% | 23.6% | ||
| Q3 25 | 66.4% | 12.3% | ||
| Q2 25 | 71.8% | 24.4% | ||
| Q1 25 | 70.0% | 32.7% | ||
| Q4 24 | 70.9% | 13.5% | ||
| Q3 24 | 70.9% | 23.3% | ||
| Q2 24 | 70.9% | 31.0% | ||
| Q1 24 | 66.7% | 11.3% |
营业利润率ABBVOPTX
| Q4 25 | 27.3% | 4.2% | ||
| Q3 25 | 12.1% | -17.5% | ||
| Q2 25 | 31.7% | -2.2% | ||
| Q1 25 | 28.0% | 7.5% | ||
| Q4 24 | -9.9% | -19.6% | ||
| Q3 24 | 26.5% | 1.4% | ||
| Q2 24 | 27.6% | 2.3% | ||
| Q1 24 | 22.7% | -22.5% |
净利率ABBVOPTX
| Q4 25 | 10.9% | -4.6% | ||
| Q3 25 | 1.2% | -20.6% | ||
| Q2 25 | 6.1% | -5.2% | ||
| Q1 25 | 9.6% | 4.6% | ||
| Q4 24 | -0.1% | -21.0% | ||
| Q3 24 | 10.8% | -0.2% | ||
| Q2 24 | 9.5% | 4.0% | ||
| Q1 24 | 11.1% | -19.3% |
每股收益（稀释后）ABBVOPTX
| Q4 25 | $1.02 | $-0.01 | ||
| Q3 25 | $0.10 | $-0.04 | ||
| Q2 25 | $0.52 | $-0.01 | ||
| Q1 25 | $0.72 | $0.01 | ||
| Q4 24 | $-0.03 | $-0.05 | ||
| Q3 24 | $0.88 | $0.00 | ||
| Q2 24 | $0.77 | $0.01 | ||
| Q1 24 | $0.77 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.3B | — |
| 总债务越低越好 | $58.9B | $2.6M |
| 股东权益账面价值 | $-3.3B | $9.5M |
| 总资产 | $134.0B | $24.3M |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资ABBVOPTX
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.7B | — | ||
| Q2 25 | $6.5B | — | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $7.3B | — | ||
| Q2 24 | $13.2B | — | ||
| Q1 24 | $18.1B | — |
总债务ABBVOPTX
| Q4 25 | $58.9B | $2.6M | ||
| Q3 25 | $63.0B | $2.7M | ||
| Q2 25 | $63.0B | $2.9M | ||
| Q1 25 | $64.5B | $3.0M | ||
| Q4 24 | $60.3B | $3.1M | ||
| Q3 24 | $58.5B | $3.2M | ||
| Q2 24 | $58.0B | $2.8M | ||
| Q1 24 | $63.8B | $3.0M |
股东权益ABBVOPTX
| Q4 25 | $-3.3B | $9.5M | ||
| Q3 25 | $-2.6B | $9.8M | ||
| Q2 25 | $-183.0M | $11.0M | ||
| Q1 25 | $1.4B | $11.4M | ||
| Q4 24 | $3.3B | $11.0M | ||
| Q3 24 | $6.0B | $12.1M | ||
| Q2 24 | $6.8B | $12.1M | ||
| Q1 24 | $8.0B | $11.9M |
总资产ABBVOPTX
| Q4 25 | $134.0B | $24.3M | ||
| Q3 25 | $133.9B | $24.6M | ||
| Q2 25 | $137.2B | $25.3M | ||
| Q1 25 | $136.2B | $26.3M | ||
| Q4 24 | $135.2B | $26.0M | ||
| Q3 24 | $143.4B | $27.3M | ||
| Q2 24 | $141.9B | $25.8M | ||
| Q1 24 | $148.9B | $24.6M |
负债/权益比ABBVOPTX
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.28× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | 45.44× | 0.26× | ||
| Q4 24 | 18.15× | 0.28× | ||
| Q3 24 | 9.70× | 0.26× | ||
| Q2 24 | 8.56× | 0.23× | ||
| Q1 24 | 7.97× | 0.25× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $-3.9K |
| 自由现金流经营现金流 - 资本支出 | $4.9B | $-4.4K |
| 自由现金流率自由现金流/营收 | 29.4% | -0.1% |
| 资本支出强度资本支出/营收 | 2.0% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.87× | — |
| 过去12个月自由现金流最近4个季度 | $17.8B | $28.3K |
8季度趋势，按日历期对齐
经营现金流ABBVOPTX
| Q4 25 | $5.2B | $-3.9K | ||
| Q3 25 | $7.0B | $535.3K | ||
| Q2 25 | $5.2B | $-158.0K | ||
| Q1 25 | $1.6B | $299.3K | ||
| Q4 24 | $7.0B | $623.8K | ||
| Q3 24 | $5.4B | $417.3K | ||
| Q2 24 | $2.3B | $-1.7M | ||
| Q1 24 | $4.0B | $-289.8K |
自由现金流ABBVOPTX
| Q4 25 | $4.9B | $-4.4K | ||
| Q3 25 | $6.6B | $496.3K | ||
| Q2 25 | $4.9B | $-548.1K | ||
| Q1 25 | $1.4B | $84.6K | ||
| Q4 24 | $6.8B | $12.1K | ||
| Q3 24 | $5.2B | $43.8K | ||
| Q2 24 | $2.0B | $-1.9M | ||
| Q1 24 | $3.8B | $-385.1K |
自由现金流率ABBVOPTX
| Q4 25 | 29.4% | -0.1% | ||
| Q3 25 | 42.1% | 7.1% | ||
| Q2 25 | 31.7% | -8.4% | ||
| Q1 25 | 10.5% | 1.2% | ||
| Q4 24 | 44.7% | 0.2% | ||
| Q3 24 | 35.9% | 0.6% | ||
| Q2 24 | 14.0% | -26.5% | ||
| Q1 24 | 31.3% | -6.2% |
资本支出强度ABBVOPTX
| Q4 25 | 2.0% | 0.0% | ||
| Q3 25 | 2.4% | 0.6% | ||
| Q2 25 | 1.7% | 5.9% | ||
| Q1 25 | 1.8% | 3.0% | ||
| Q4 24 | 1.9% | 8.4% | ||
| Q3 24 | 1.7% | 4.7% | ||
| Q2 24 | 1.7% | 2.3% | ||
| Q1 24 | 1.6% | 1.5% |
现金转化率ABBVOPTX
| Q4 25 | 2.87× | — | ||
| Q3 25 | 37.76× | — | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 1.27× | 0.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | -6.01× | ||
| Q1 24 | 2.95× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
